10.01.20
Gencor announced the introduction of its newest ingredient, Tesnor, a combination of the extracts of cocoa bean (Theobroma cacao) and pomegranate peel (Punica granatum), which has been shown in clinical trials to improve testosterone levels in healthy, aging men, as well as to reduce aging male symptoms (AMS) scores.
Tesnor is an IP-protected, food-derived, and standardized extract, which is shown to have a mechanism of action involving an increase of in-cell testosterone production, and an inhibition of aromatase activity. In addition to clinical trials supporting its role in improving age-related male symptoms, Tesnor was shown to support muscle strength and growth in young males.
“We are thrilled to add another clinically tested ingredient to our healthy aging and sports nutrition ingredient portfolio,” Chase Shryoc, vice president of Sales and Business Development for Gencor, said. “Tesnor is a well-researched ingredient with an excellent safety profile which meets global regulations. It has been tested with NSF and LGC for absence of WADA prohibited substances, and it offers versatility in its ability to be applied in a variety of formats to meet the on-the-go consumer demands.”
“We expect Tesnor to be a strong contender in the men’s health marketplace due to its numerous application formats,” he continued. “We look forward to sharing the overwhelming positive results demonstrated in clinical studies for both young and aging males.”
To date, one human clinical trial involving 119 participants between the ages of 21 and 35 years old showed that daily supplementation of Tesnor resulted in significant improvements in serum levels of testosterone compared to placebo, with secondary outcomes of increased hormones, hand-grip strength, and mid-upper arm circumference.
The clinical trial evaluating its impact on aging male symptoms, which was a double-blind, placebo-controlled, and randomized study enrolling 131 people, also found several significant improvements. Aging male symptoms tend to begin in men at around 40 years of age, associated with age-related declines in testosterone. The symptoms tend to effect sexual function, libido, and can include psychological symptoms such as anxiety and depression, as well as a number of somatic symptoms including diminished sense of well-being, decreased muscle strength, muscle and joint pain, insomnia, and physical exhaustion.
Prior to these studies, a trial involving Sprague Dawley rats concluded that daily supplementation with Tensor resulted in increased serum testosterone levels by an average of 45% in 14 days, and improved semen quality.
Synopses of these trials can be found online.
Tesnor is an IP-protected, food-derived, and standardized extract, which is shown to have a mechanism of action involving an increase of in-cell testosterone production, and an inhibition of aromatase activity. In addition to clinical trials supporting its role in improving age-related male symptoms, Tesnor was shown to support muscle strength and growth in young males.
“We are thrilled to add another clinically tested ingredient to our healthy aging and sports nutrition ingredient portfolio,” Chase Shryoc, vice president of Sales and Business Development for Gencor, said. “Tesnor is a well-researched ingredient with an excellent safety profile which meets global regulations. It has been tested with NSF and LGC for absence of WADA prohibited substances, and it offers versatility in its ability to be applied in a variety of formats to meet the on-the-go consumer demands.”
“We expect Tesnor to be a strong contender in the men’s health marketplace due to its numerous application formats,” he continued. “We look forward to sharing the overwhelming positive results demonstrated in clinical studies for both young and aging males.”
To date, one human clinical trial involving 119 participants between the ages of 21 and 35 years old showed that daily supplementation of Tesnor resulted in significant improvements in serum levels of testosterone compared to placebo, with secondary outcomes of increased hormones, hand-grip strength, and mid-upper arm circumference.
The clinical trial evaluating its impact on aging male symptoms, which was a double-blind, placebo-controlled, and randomized study enrolling 131 people, also found several significant improvements. Aging male symptoms tend to begin in men at around 40 years of age, associated with age-related declines in testosterone. The symptoms tend to effect sexual function, libido, and can include psychological symptoms such as anxiety and depression, as well as a number of somatic symptoms including diminished sense of well-being, decreased muscle strength, muscle and joint pain, insomnia, and physical exhaustion.
Prior to these studies, a trial involving Sprague Dawley rats concluded that daily supplementation with Tensor resulted in increased serum testosterone levels by an average of 45% in 14 days, and improved semen quality.
Synopses of these trials can be found online.
